| Recruiting | Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthropla Circulatory Disease | Phase 2 | 2025-01-20 |
| Recruiting | A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis Reflux Esophagitis (RE) | Phase 3 | 2024-12-05 |
| Unknown | A Study to Evaluate the Efficacy and Safety of LZM012 Psoriasis | Phase 3 | 2023-08-21 |
| Unknown | A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine COVID-19 Pandemic | EARLY_Phase 1 | 2022-09-16 |
| Unknown | Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351 COVID-19 Pandemic | EARLY_Phase 1 | 2022-08-15 |
| Unknown | The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine COVID-19 Pandemic | Phase 2 | 2022-01-11 |
| Unknown | Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine COVID-19 Pandemic | Phase 2 | 2021-11-10 |
| Completed | Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study COVID-19 Pandemic | Phase 3 | 2021-11-03 |
| Unknown | Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization COVID-19 Pandemic | N/A | 2021-09-30 |
| Unknown | Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III COVID-19 Pandemic | Phase 3 | 2021-08-25 |
| Completed | Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) COVID19 | Phase 1 | 2021-08-07 |
| Unknown | Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogenc COVID-19 Pandemic | Phase 2 | 2021-08-05 |
| Completed | A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Sa Stress Ulcer Bleeding | Phase 3 | 2021-07-16 |
| Completed | Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Solid Tumor Refractory to Standard Therapy | Phase 1 | 2018-10-03 |
| Unknown | Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Patients(BCS) With Digestive Tract . Carcinogenic Fatigue | N/A | 2018-01-18 |
| Unknown | Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Chemo Patients With Digestive Tract . Digestive Tract | N/A | 2017-12-24 |
| Completed | LZM009 to Treat Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2017-08-21 |
| Completed | Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients Peptic Ulcer Hemorrhage | Phase 3 | 2014-10-01 |
| Completed | Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori Helicobacter Pylori Eradication | Phase 4 | 2014-09-01 |
| Unknown | Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH Oligospermia, Azoospermia | Phase 4 | 2014-08-01 |
| Completed | IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients Peptic Ulcer Hemorrhage | Phase 2 | 2014-02-01 |
| Completed | Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of H Helicobacter Pylori Eradication Antibiotic | Phase 4 | 2013-06-01 |
| Completed | Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients Gastroesophageal Reflux Disease | Phase 3 | 2011-12-01 |
| Unknown | Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients Gastroesophageal Reflux Disease | Phase 2 | 2010-05-01 |
| Completed | Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients Duodenal Ulcer | Phase 2 / Phase 3 | 2008-08-01 |
| Completed | Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3) Duodenal Ulcer | Phase 3 | 2005-09-01 |
| Completed | Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2) Duodenal Ulcer | Phase 2 | 2004-10-01 |